Evidence map›Paper›PMID 34042191›Full record

ArticleJournal of medical virology2021

Does the COVID-19 seroconversion in older adults resemble the young?

Rabia Bag Soytas, Mahir Cengiz, Mehmet Sami Islamoglu, Betul Borku Uysal, Hande Ikitimur, Hakan Yavuzer, Serap Yavuzer

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of medical virology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Rabia Bag SoytasDivision of Geriatrics, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-9620-7596
Mahir CengizDepartment of Internal Medicine, Biruni University Medical Faculty, Istanbul, Turkey.ORCID https://orcid.org/0000-0003-3343-8650
Mehmet Sami IslamogluDepartment of Internal Medicine, Biruni University Medical Faculty, Istanbul, Turkey.ORCID http://orcid.org/0000-0003-3426-6950
Betul Borku UysalDepartment of Internal Medicine, Biruni University Medical Faculty, Istanbul, Turkey.ORCID http://orcid.org/0000-0001-9292-5024
Hande IkitimurDepartment of Pulmonary Diseases, Biruni University Medical Faculty, Istanbul, Turkey.ORCID https://orcid.org/0000-0002-7917-1771
Hakan YavuzerDivision of Geriatrics, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey.ORCID https://orcid.org/0000-0003-2685-6555
Serap YavuzerDepartment of Internal Medicine, Biruni University Medical Faculty, Istanbul, Turkey.ORCID https://orcid.org/0000-0001-7618-9987
Biruni University · TRIstanbul University-Cerrahpaşa · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High antibody titers have been found to correlate with the severity of coronavirus disease 2019 (COVID-19) disease. Therefore, antibody titers may be higher in older adults, whose disease is known to have a more severe course than younger ones. This study aimed to compare the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) antibody level in the reverse transcription-polymerase chain reaction (RT-PCR) to test positive older adults with young. Patients aged ≥18 with positive RT-PCR and checked serum IgG antibodies between November 1, 2020 and January 13, 2021 were included. The IgG antibody levels and the time between RT-PCR positivity with the antibody levels were recorded. A total of 1071 patients were divided into two groups as Group 1 <60 years old (n = 902) and Group 2 ≥60 years old (n = 169). The SARS-CoV-2 IgG antibody titers were higher in Group 2 (p = 0.001). This height was present in the first 3 months after positive RT-PCR. While the antibody titers were compared by dividing Group 2 into the three groups according to age ranges (60-69, 70-79, and ≥80 years), the antibody titer was higher in ≥80 years patients (p = 0.044). High COVID-19 IgG antibody levels may be associated with the severity of the disease. Also, the humoral immunity advantage was seen in the first 3 months in the older patients, which suggests that older adults with COVID-19 may develop reinfection in the long term.

Indexed as

SeroconversionAdultAgedAged, 80 and overAge FactorsAntibodies, ViralCOVID-19FemaleHumansImmunoglobulin GMaleMiddle AgedSARS-CoV-2Time FactorsAntibodies, ViralImmunoglobulin GantibodyCOVID-19older adultsSARS-CoV-2seroconversion

Identifiers

PMID34042191
PMCPMC8242906
OpenAlexW3164103720

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.